Fig. 1 (abstract P85).From: Abstracts from the International Society for Therapeutic Ultrasound Conference 2017A: FasL expression in prostate cancer cells at 2, 24 and 72 hours post treatment. B: Fas (CD95) expression in prostate cancer cells at 2, 24 and 72 hours. C: TNFÂα expression in prostate cancer cells at 2, 24 and 72 hours post treatment. D: HSP70 expression in prostate cancer cell at 2 and 24 hoursBack to article page